Rethinking the communication of clinical trial results
The following article discusses the means by which clinical trial [...]
Update on papillary kidney cancer
The following is an interview with Dr Ramaprasad Srinivasan, Head of the [...]
KCSN Trustee appointed as Cancer Research UK Senior Clinical Advisor in clinical research
Cancer Research UK announces the appointment of Dr James Larkin [...]
NHS Cancer Vanguard partnering with pharma to improve patient experince
As part of NHS England's Five-Year Forward View and recent [...]
Britain fails to narrow the cancer survival gap behind the best in the world
A new global study involving 37 million cancer patients in [...]
Stereotactic ablative radiotherapy (SABR) is an effective treatment for primary kidney cancer
Data from a pooled analysis published in the journal Cancer [...]
Tessa Jowell’s moving speech calling for a change in the way the NHS treats cancer
Baroness Tessa Jowell received a standing ovation after delivering moving [...]
Post-nephrectomy diet to reduce the risk of kidney disease
Recent studies have suggested that nephrectomy, either for kidney donation [...]
Scientists discover the mechanism for resistance to immunotherapy treatment
Scientists from the Dana-Farber Cancer Institute in Boston, USA, have [...]
Missed appointments are costing the NHS £1 billion per year
An article in The Times reports that NHS England health [...]
